Cannabis federal reform has finally reached a historic moment. Medical cannabis is moving through the rescheduling process after decades under federal prohibition, marking one of the biggest developments in the industry’s history.
The final outcome could determine how companies expand, whether cannabis can move across state lines, and which markets become the next major opportunities.
Hirsh Jain, CEO of Ananda Strategy, shares his perspective on where rescheduling stands, whether interstate commerce will be allowed, and which states businesses should be watching next.